Promising patient studies surrounding this compound, specifically the high-dose formulation ZPHC ZPHC, indicate a significant effect on body mass loss and linked health factors. Researchers believe that this combined compound, targeting both GLP-1 and GIP receptors , has the potential to represent a noteworthy improvement in the management of exce